Australia markets open in 9 hours 22 minutes

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2500-0.0800 (-3.43%)
At close: 04:00PM EST
2.2500 0.00 (0.00%)
Pre-market: 07:40AM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.3300
Open2.3500
Bid1.5000 x 800
Ask2.4600 x 1000
Day's range2.2000 - 2.3500
52-week range1.5300 - 32.4000
Volume33,739
Avg. volume44,298
Market cap28.702M
Beta (5Y monthly)1.87
PE ratio (TTM)N/A
EPS (TTM)-14.8540
Earnings date02 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.00
  • GlobeNewswire

    Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering priced at the market under Nasdaq rules of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common

  • GlobeNewswire

    Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

    DEERFIELD, Ill., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that it has entered into a definitive agreement with a single institutional investor for the sale and issuance of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000 shares of common

  • GlobeNewswire

    Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas

    Company plans to realign in an effort to improve efficiencies, while lowering its capital requirements to invest in innovation; estimated cash savings in 2023 are expected to be approximately $30 - $35 millionDEERFIELD, Ill., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that its Board of Directors has approved a corporate restruct